BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design

Vista sencilla de ítem
dc.contributor.authorCovián, Camilaa
dc.contributor.authorFernández-Fierro, Ayleen
dc.contributor.authorRetamal-Díaz, Angello
dc.contributor.authorDíaz, Fabián E
dc.contributor.authorVasquez, Abel E.
dc.contributor.authorLay, Margarita K
dc.contributor.authorRiedel, Claudia A
dc.contributor.authorGonzález, Pablo A
dc.contributor.authorBueno, Susan M.
dc.contributor.authorKalergis, Alexis M
dc.date.accessioned2022-10-17T12:40:08Z
dc.date.available2022-10-17T12:40:08Z
dc.date.issued2019-11
dc.description.abstractThe Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the ability to induce non-specific cross-protection against pathogens that might be unrelated to the target disease. Vaccination with BCG reduces mortality in newborns and induces an improved innate immune response against microorganisms other than Mycobacterium tuberculosis, such as Candida albicans and Staphylococcus aureus. Innate immune cells, including monocytes and natural killer (NK) cells, contribute to this non-specific immune protection in a way that is independent of memory T or B cells. This phenomenon associated with a memory-like response in innate immune cells is known as “trained immunity.” Epigenetic reprogramming through histone modification in the regulatory elements of particular genes has been reported as one of the mechanisms associated with the induction of trained immunity in both, humans and mice. Indeed, it has been shown that BCG vaccination induces changes in the methylation pattern of histones associated with specific genes in circulating monocytes leading to a “trained” state. Importantly, these modifications can lead to the expression and/or repression of genes that are related to increased protection against secondary infections after vaccination, with improved pathogen recognition and faster inflammatory responses. In this review, we discuss BCG-induced cross-protection and acquisition of trained immunity and potential heterologous effects of recombinant BCG vaccines. © Copyright © 2019 Covián, Fernández-Fierro, Retamal-Díaz, Díaz, Vasquez, Lay, Riedel, González, Bueno and Kalergis.es
dc.description.sponsorshipIndexación: Scopuses
dc.identifier.citationFrontiers in Immunology Open AccessVolume 1029 November 2019 Article number 2806es
dc.identifier.issn16643224
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/24287
dc.language.isoenes
dc.publisherFrontiers Media S.A.es
dc.subjectBCG; heterologous protection; innate immunity; trained immunity; vaccinees
dc.titleBCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Designes
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Covián Camila_BCG-Induced Cross-Protection and Development of Trained Immunity.pdf
Tamaño:
960.41 KB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista